Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy.

STUDY OBJECTIVE

To determine the incidence of unanticipated uterine pathologic findings in women undergoing hysterectomy concomitant with minimally invasive sacrocolpopexy.

DESIGN

Retrospective case series (Canadian Task Force classification III).

SETTING

Four institutions in the United States.

PATIENTS

Women undergoing laparoscopic or robotically assisted sacrocolpopexy with hysterectomy.

INTERVENTIONS

Concurrent hysterectomy and minimally invasive sacrocolpopexy.

MEASUREMENTS AND MAIN RESULTS

We measured the incidence of clinically important uterine disease at minimally invasive sacrocolpopexy. A total of 324 women underwent concurrent hysterectomy and minimally invasive sacrocolpopexy. Their mean age was 56.1 years, and body mass index was 26.9 kg/m(2). Sixty-four percent were postmenopausal. Only 3 patients (0.92%) had abnormal uterine pathologic findings. No significant differences were noted in age, body mass index, or parity between the women with normal and abnormal uterine pathologic findings. None of the 3 women reported abnormal uterine bleeding before surgery. All lesions were premalignant and focal. No invasive carcinomas were identified. No patients required further follow-up or treatment of abnormal pathologic findings.

CONCLUSION

The risk of unanticipated uterine pathologic findings during minimally invasive sacrocolpopexy to treat pelvic organ prolapse is low.